Research Articles | Page 24 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria Mar 2021 Blood cells, molecules and diseases Paroxysmal Nocturnal Hemoglobinuria (PNH)
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome Apr 2023 Blood Cancer Myelodysplastic Syndromes (MDS)
Modified Delphi Panel Consensus Recommendations for Management of Severe Aplastic Anemia Apr 2024 Blood Advances Aplastic Anemia
Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse Jul 2020 Blood Advances Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study Dec 2023 Blood Advances Aplastic Anemia
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients Jun 2019 Blood Advances Myelodysplastic Syndromes (MDS)
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Health-Related Quality of Life and Vulnerability among People with Myelodysplastic Syndromes: A US National Study May 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)